| |
| |
|
| Insider
Information: |
Hansen Gwenn |
| Relationship: |
Chief Scientific Officer |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
39,601 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
39,601 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nurix Therapeutics, Inc. |
NRIX |
Chief Scientific Officer |
2024-04-30 |
39,601 |
2020-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-11-30 |
4 |
OE |
$0.84 |
$10,080 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-02-18 |
4 |
OE |
$7.26 |
$5,808 |
D/D |
800 |
12,800 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-02-18 |
4 |
AS |
$35.81 |
$29,018 |
D/D |
(800) |
12,000 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-03-01 |
4 |
OE |
$7.26 |
$5,808 |
D/D |
800 |
14,604 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-03-01 |
4 |
AS |
$35.95 |
$28,760 |
D/D |
(800) |
13,804 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-03-16 |
4 |
AS |
$45.00 |
$36,000 |
D/D |
(800) |
13,804 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-03-16 |
4 |
OE |
$7.26 |
$5,808 |
D/D |
800 |
14,604 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-04-01 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,204 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-04-01 |
4 |
AS |
$31.55 |
$12,620 |
D/D |
(400) |
13,804 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-05-03 |
4 |
OE |
$7.26 |
$5,808 |
D/D |
800 |
14,604 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-05-03 |
4 |
AS |
$35.00 |
$27,996 |
D/D |
(800) |
13,804 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-01 |
4 |
AS |
$27.74 |
$11,096 |
D/D |
(400) |
13,804 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-01 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,204 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-07-01 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,204 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-07-01 |
4 |
AS |
$26.76 |
$10,704 |
D/D |
(400) |
13,804 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-08-02 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,204 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-08-02 |
4 |
AS |
$31.21 |
$12,484 |
D/D |
(400) |
13,804 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-09-01 |
4 |
AS |
$32.34 |
$12,936 |
D/D |
(400) |
14,197 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-09-01 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,597 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-09-07 |
4 |
OE |
$7.26 |
$11,616 |
D/D |
1,600 |
15,797 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-09-07 |
4 |
AS |
$35.00 |
$56,000 |
D/D |
(1,600) |
14,197 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-10-01 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,597 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-10-01 |
4 |
AS |
$29.92 |
$11,968 |
D/D |
(400) |
14,197 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-10-27 |
4 |
AS |
$35.00 |
$14,000 |
D/D |
(400) |
14,197 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-10-27 |
4 |
OE |
$7.26 |
$2,904 |
D/D |
400 |
14,597 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
